Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera.
D000230:Adenocarcinoma / Q000276:immunology*; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D003470:Culture Media; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000276:immunology*
D000961:Antilymphocyte Serum; D003470:Culture Media